Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Feng Zhang unveils a new technology to potentially deliver mRNA, gene therapy, CRISPR and more
4 years ago
Discovery
Cell/Gene Tx
J&J's Alex Gorsky set to step away from CEO role, handing the reins to Covid-19 czar Joaquin Duato
4 years ago
Pharma
Biotech co-founder settles major research misconduct allegations with HHS
4 years ago
SEC charges former Medivation exec with insider trading prior to Pfizer acquisition
4 years ago
Pharma
Prosecutors secure guilty plea in $110M biotech scam at Vermont ski resort
4 years ago
As Aubrey de Grey investigation swirled, SENS CEO left foundation in July — report
4 years ago
Sen. Rand Paul reveals his wife bought Gilead stock in February 2020 — 16 months after filing deadline
4 years ago
Pharma
Leading anti-aging researcher Aubrey de Grey accused of sexual harassment by two colleagues, including while one was a minor
4 years ago
'The consummate mentor': Bill Clinton, Jim Wilson and others reflect on Tachi Yamada's life and legacy
4 years ago
In Focus
Opinion: Plenty of qualified people are ready to run the FDA. Time for Biden to choose one
4 years ago
FDA+
A decades-old glaucoma drug tossed aside by Pfizer gets a new life at a small biotech
4 years ago
Deals
Former BARDA director settles whistleblower case on Trump's mismanagement of the pandemic
4 years ago
Coronavirus
Science pioneer, pharma research chief, global health advocate and biotech entrepreneur Tadataka ‘Tachi’ Yamada has died
4 years ago
Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how
4 years ago
Startups
Ardelyx chops a third of its staff after stock-crushing failure in chronic kidney disease
4 years ago
FDA+
Synbio unicorn Zymergen jettisons founding CEO, cuts guidance as customers report lead product doesn't work
4 years ago
R&D
Going so soon? Scholar Rock CEO makes swift exit, leaving Nagesh Mahanthappa back at the helm
4 years ago
Gilead lands in North Carolina with a plan to hire 300 for new center
4 years ago
Flush with cash, Rakuten billionaire Mickey Mikitani looks to take his photoimmunotherapy platform global
4 years ago
Financing
Chinese researcher — and former 'fugitive' — returns home after DOJ moves to drop a spate of cases
4 years ago
China
Bob Nelsen's ARCH adds FDA, biodefense expertise with appointment of Luciana Borio
4 years ago
Ex-Merck chief Ken Frazier takes a leading role in a $600M 'Health Assurance' venture fund
4 years ago
A top Morgan Stanley sell-side analyst makes the jump from outside player to biotech C-suite insider
4 years ago
Sean Parker-backed cell therapy startup ArsenalBio plucks Merck VP as new CSO
4 years ago
Cell/Gene Tx
First page
Previous page
55
56
57
58
59
60
61
Next page
Last page